|
Volumn 6, Issue 13, 2010, Pages 1442-1448
|
Combinatorial drug conjugation enables nanoparticle dual-drug delivery
|
Author keywords
Cancer therapy; Conjugation; Drug delivery; Lipid polymer hybrids; Nanoparticles
|
Indexed keywords
CANCER THERAPY;
CONJUGATION;
DELIVERY VEHICLE;
DRUG-CONJUGATES;
GEMCITABINE;
HYDROLYSIS KINETICS;
NANOCARRIERS;
NEW APPROACHES;
PACLITAXEL;
PANCREATIC CANCERS;
POLYMER HYBRID;
PROOF OF CONCEPT;
STOICHIOMETRIC RATIO;
SYNTHESIS AND CHARACTERIZATION;
TARGET CELLS;
THERAPEUTIC ACTIVITY;
THERAPEUTIC AGENTS;
TIME-DEPENDENT;
AMPHIPHILES;
DRUG DELIVERY;
LOADING;
NANOPARTICLES;
ONCOLOGY;
POLYMERS;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
LIPID;
NANOPARTICLE;
PACLITAXEL;
ARTICLE;
CELL DEATH;
CHEMISTRY;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
HUMAN;
HYDROLYSIS;
METHODOLOGY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
SYNTHESIS;
TUMOR CELL LINE;
CELL DEATH;
CELL LINE, TUMOR;
DEOXYCYTIDINE;
DRUG DELIVERY SYSTEMS;
HUMANS;
HYDROLYSIS;
LIPIDS;
MAGNETIC RESONANCE SPECTROSCOPY;
NANOPARTICLES;
PACLITAXEL;
|
EID: 77954302022
PISSN: 16136810
EISSN: 16136829
Source Type: Journal
DOI: 10.1002/smll.201000631 Document Type: Article |
Times cited : (158)
|
References (27)
|